Publications:

Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120.

Biochemistry

Gift, Syna Kuriakose SK; McFadden, Karyn K; Zentner, Isaac J IJ; Rajagopal, Srivats S; Zhang, Mei-Yun MY; Dimitrov, Dimiter S DS; Chaiken, Irwin M IM

Publication Date: 2011-04-12

Variant appearance in text: CD4: S56A

PubMed Link: 21417283

Variant Present in the following documents:

• Main text

View BVdb publication page

β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.

Retrovirology

Tervo, Hanna-Mari HM; Homann, Stefanie S; Ambiel, Ina I; Fritz, Joëlle V JV; Fackler, Oliver T OT; Keppler, Oliver T OT

Publication Date: 2011-02-10

Variant appearance in text: CD4: S56A

PubMed Link: 21310048

Variant Present in the following documents:

• Main text
• 1742-4690-8-9.pdf

View BVdb publication page

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

Plos Pathogens

Mangeat, Bastien B; Gers-Huber, Gustavo G; Lehmann, Martin M; Zufferey, Madeleine M; Luban, Jeremy J; Piguet, Vincent V

Publication Date: 2009-09

Variant appearance in text: CD4: S56A

PubMed Link: 19730691

Variant Present in the following documents:

• Main text

View BVdb publication page

Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.

Plos Pathogens

Estrabaud, Emilie E; Le Rouzic, Erwann E; Lopez-Vergès, Sandra S; Morel, Marina M; Belaïdouni, Nadia N; Benarous, Richard R; Transy, Catherine C; Berlioz-Torrent, Clarisse C; Margottin-Goguet, Florence F

Publication Date: 2007-07-27

Variant appearance in text: CD4: S56A

PubMed Link: 17676996

Variant Present in the following documents:

• Main text
• ppat.0030104.pdf

View BVdb publication page